Our Mission

PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.

Click the orange button to the right to learn more.

Gemcitabine + Cisplatin (GemCis) for Cancer: What Patients Need to Know

Share Button

Gemcitabine + Cisplatin (GemCis) for Cancer: What Patients Need to Know. Learn how Gemcitabine + Cisplatin chemotherapy works, common side effects, evidence-based complementary therapies, and practical recovery strategies for cancer patients.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Before beginning gemcitabine + cisplatin (GemCis) for cancer, consider:

Scroll down the page and post a question or a comment if there’s anything you’d like to know about carboplatin + paclitaxel for cancer.

Good luck,

David Emerson

Gemcitabine + Cisplatin (GemCis) for Cancer


Concepts Central to Managing Your Cancer-


Gemcitabine + Cisplatin (GemCis): An Effective Chemotherapy with Manageable Side Effects

If you’ve recently been diagnosed with bladder cancer, biliary tract cancer, non-small cell lung cancer, mesothelioma, cervical cancer, ovarian cancer, or pancreatic cancer, your oncologist may recommend Gemcitabine + Cisplatin, often shortened to GemCis or GC.

This combination has become one of the world’s most commonly used platinum-based chemotherapy regimens because it combines two drugs that attack cancer cells in different ways while producing better response rates than either drug alone.

Although GemCis is effective, it can also produce predictable side effects—many of which can be reduced through proactive supportive care, nutrition, exercise, and evidence-based complementary therapies.

As a cancer survivor myself, I’ve learned that preparing before side effects occur is often the best way to stay healthier throughout treatment.


What is GemCis?

GemCis combines:

Gemcitabine (Gemzar®)

  • Antimetabolite chemotherapy
  • Blocks DNA synthesis
  • Prevents cancer cells from dividing

Cisplatin (Platinol®)

  • Platinum chemotherapy
  • Damages cancer cell DNA
  • Causes irreversible DNA cross-linking leading to cell death

Because they attack cancer differently, the combination is more effective than either drug alone.


Which Cancers Are Treated with GemCis?

GemCis is commonly used for:

  • Bladder cancer
  • Biliary tract cancer (cholangiocarcinoma and gallbladder cancer)
  • Non-small cell lung cancer
  • Malignant mesothelioma
  • Cervical cancer
  • Ovarian cancer
  • Pancreatic cancer (selected patients)
  • Nasopharyngeal cancer
  • Other advanced solid tumors depending on clinical circumstances

Typical Treatment Schedule

Although schedules vary by cancer type, a common regimen is:

Day 1

  • Gemcitabine infusion
  • Cisplatin infusion

Day 8

  • Gemcitabine infusion

Days 9–21

Recovery period

Then the cycle repeats every 21 days, usually for 4–6 cycles, depending on the cancer type and treatment goals.


Most Common Side Effects

Side Effect Frequency Usually Temporary?
Fatigue Very common Usually
Nausea/Vomiting Very common Yes
Low white blood cells Very common Yes
Low platelets Common Yes
Anemia Common Often
Kidney injury Common Sometimes
Hearing loss Less common May be permanent
Peripheral neuropathy Common May persist
Constipation Common Yes
Appetite loss Common Yes
Electrolyte abnormalities Common Usually

The Side Effects Patients Should Understand

1. Kidney Damage (Nephrotoxicity)

This is the side effect that oncologists monitor most carefully.

Cisplatin can damage the kidneys because it accumulates in kidney tubule cells.

Your oncology team typically protects the kidneys by:

  • Large IV fluid infusions
  • Magnesium replacement
  • Potassium replacement
  • Monitoring creatinine before every treatment
  • Encouraging aggressive hydration at home

2. Peripheral Neuropathy

Cisplatin commonly damages peripheral nerves.

Symptoms include:

  • Numb fingers
  • Tingling toes
  • Burning feet
  • Difficulty buttoning clothing
  • Balance problems

Neuropathy can continue worsening for months after chemotherapy ends (“coasting”).

Evidence-based supportive therapies include:

  • Exercise
  • Cryotherapy (when appropriate)
  • Acupuncture
  • Alpha-lipoic acid (discuss with your oncologist)
  • Glutamine (mixed evidence)
  • Physical therapy
  • Occupational therapy

3. Hearing Loss

Cisplatin can damage the tiny hair cells inside the inner ear.

Symptoms include:

  • Ringing (tinnitus)
  • Difficulty hearing conversations
  • High-frequency hearing loss

Patients noticing hearing changes should notify their oncologist promptly. Dose adjustments or alternative platinum drugs may sometimes be considered.


4. Fatigue

Cancer-related fatigue results from multiple factors:

  • Chemotherapy
  • Anemia
  • Poor nutrition
  • Sleep disruption
  • Reduced physical activity
  • Emotional stress

One of the strongest evidence-based treatments is regular moderate exercise, even during chemotherapy.


5. Low Blood Counts

Gemcitabine suppresses bone marrow.

Possible consequences include:

  • Infection risk
  • Bleeding
  • Fatigue
  • Treatment delays

Helpful strategies include:

  • Good hand hygiene
  • Adequate protein intake
  • Prompt reporting of fever (≥100.4°F / 38°C)
  • Following blood count monitoring schedules

Evidence-Based Integrative Therapies

Therapy Side Effect Evidence Comments
Exercise Fatigue ★★★★★ Strongest evidence
Acupuncture Nausea, neuropathy ★★★★☆ Good supportive evidence
Ginger Nausea ★★★★☆ Helpful with antiemetics
Meditation Anxiety ★★★★★ Excellent evidence
Protein-rich diet Recovery ★★★★☆ Supports healing
Hydration Kidney protection ★★★★★ Critical with cisplatin
Sleep optimization Fatigue ★★★★☆ Improves resilience
Cryotherapy Neuropathy ★★★☆☆ Emerging evidence
Magnesium (if deficient) Cisplatin-associated electrolyte loss ★★★★☆ Replace under medical supervision

Practical Tips During Treatment

Many patients tolerate GemCis better by:

  • Drinking plenty of fluids before and after treatment (follow your oncology team’s guidance)
  • Taking anti-nausea medications exactly as prescribed
  • Walking daily, even if only 15–20 minutes
  • Eating small, protein-rich meals
  • Reporting numbness or tingling early
  • Avoiding dehydration
  • Monitoring for fever or signs of infection
  • Keeping a daily symptom diary to identify trends

Questions to Ask Your Oncologist

  • What is the goal of my GemCis treatment?
  • How many cycles do you recommend?
  • What kidney function tests will be monitored?
  • Should I receive magnesium or potassium supplementation?
  • What symptoms require an urgent phone call?
  • What can be done if neuropathy develops?
  • Would physical therapy help if balance problems occur?
  • Should I have a hearing test before or during treatment?
  • Are there clinical trials available for my cancer?

Evidence Rating

Intervention Evidence
Exercise ★★★★★
Modern anti-nausea medications ★★★★★
Hydration protocols ★★★★★
Acupuncture ★★★★☆
Ginger ★★★★☆
Sleep optimization ★★★★☆
Protein nutrition ★★★★☆
Cryotherapy ★★★☆☆
Alpha-lipoic acid ★★☆☆☆ (mixed evidence)

To learn more:

To prepare for Gemcitabine + Cisplatin (GemCis)-

Gemcitabine + Cisplatin (GemCis) induced side effects-

Lifestyle Post Therapy

Comparison Chemotherapy-regimens:


Research References

Seminal Trials

  1. Von der Maase H, et al. J Clin Oncol. 2000. Gemcitabine plus cisplatin versus MVAC in advanced bladder cancer.
  2. Valle J, et al. N Engl J Med. 2010. ABC-02 trial establishing GemCis as standard first-line therapy for advanced biliary tract cancer.
  3. Sandler AB, et al. J Clin Oncol. Gemcitabine plus cisplatin in advanced NSCLC.

Supportive Care
4. ASCO Guidelines: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy.
5. ASCO Guidelines: Exercise During Cancer Treatment.
6. ASCO Guidelines: Cancer-Related Fatigue.
7. MASCC/ESMO Antiemetic Guidelines.
8. KDIGO Clinical Practice Guideline for Acute Kidney Injury.
9. Cochrane Review: Acupuncture for chemotherapy-induced nausea and vomiting.
10. National Cancer Institute. Gemcitabine-Cisplatin regimen overview.

Leave a Comment: